Compensation & Unmixing Plus Viability. Introducing ViaComp® Ultra™ XT – Amine.
Slingshot Logo 2026 TM.svg
Jul 30, 2026

Novel Synthetic Hydrogel Reference Controls for Confirming Cross-Instrument Equivalence in Cell Therapy Manufacturing

AuthorSlingshot Biosciences
Share Article
View Resource

Keep Reading

All
thumbnail-1 1.jpg
Group 57 (1).png
Slingshot Biosciences

Custom TruCytes® Controls Validate Prognostic FcγRIIa Flow Cytometry Test on Fixed Platelets

Read Case Study
thumbnail-10 1.jpg
Group 57 (1).png
Slingshot Biosciences
Research

Development of a Ki-67 Expressing Cell Mimic for Assay Validation at Cerba Research

Read Case Study
thumbnail-12 1.jpg
Group 57 (1).png
Slingshot Biosciences
Research

Development of Non-Biohazardous p24 Antigen Expressing Cell Mimics as a Reference Control Alternative to HIV+ Donor Samples

Read Case Study